We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+5.65%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$3.31B
AUM Growth
+$72.1M
Cap. Flow
-$212M
Cap. Flow %
-6.41%
Top 10 Hldgs %
31.06%
Holding
111
New
31
Increased
21
Reduced
21
Closed
33

Top Buys

Rank Stock Value
1
AET
Aetna Inc
AET
+$92.4M
2
BIIB icon
Biogen
BIIB
+$88.4M
3
BAX icon
Baxter International
BAX
+$59.5M
4
DISH
DISH Network Corp.
DISH
+$58.6M
5
META icon
Meta Platforms (Facebook)
META
+$53.6M

Top Sells

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$110M
2
AAPL icon
Apple
AAPL
+$94.8M
3
BMY icon
Bristol-Myers Squibb
BMY
+$94M
4
LRCX icon
Lam Research
LRCX
+$90.7M
5
AGN
Allergan plc
AGN
+$84.2M

Sector Composition

Rank Sector Weight
1 Healthcare 38.8%
2 Technology 9.31%
3 Communication Services 4.67%
4 Energy 3.99%
5 Financials 3.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BKD icon
26
Brookdale Senior Living
BKD
$3.62B
$49.2M 1.48%
3,185,477
+1,172,484
+58% +$20.5M
VISN
27
Vistance Networks Inc
VISN
$2.66B
$48.1M 1.45%
+1,548,706
New +$46M
CBRE icon
28
CBRE Group
CBRE
$40.8B
$46.7M 1.41%
1,762,886
+1,321,107
+299% +$38.6M
AR icon
29
Antero Resources
AR
$10.9B
$45.6M 1.37%
+1,753,495
New +$47.8M
HLF icon
30
Herbalife
HLF
$1.23B
$45.3M 1.37%
1,547,308
+570,614
+58% +$17.1M
BMRN icon
31
BioMarin Pharmaceuticals
BMRN
$11.5B
$44.4M 1.34%
+571,104
New +$48.6M
PBYI icon
32
Puma Biotechnology
PBYI
$406M
$43.8M 1.32%
+1,471,879
New +$46M
XLB icon
33
CALL
State Street Materials Select Sector SPDR ETF
XLB
$8.51B
$43.1M 1.3%
+1,262,400
New +$29.4M
AERI
34
DELISTED
Aerie Pharmaceuticals
AERI
$41.2M 1.24%
2,341,640
-39,495
-2% -$639K
HOLX
35
DELISTED
Hologic
HOLX
$40.7M 1.23%
1,175,350
+720,862
+159% +$25M
HAL icon
36
Halliburton
HAL
$27.9B
$40.4M 1.22%
+892,964
New +$36.7M
BDX icon
37
Becton Dickinson
BDX
$43.1B
$39.5M 1.19%
239,012
+89,167
+60% +$14.3M
PANW icon
38
Palo Alto Networks
PANW
$264B
$39.4M 1.19%
1,927,464
-1,056,108
-35% -$24.5M
BMY icon
39
Bristol-Myers Squibb
BMY
$127B
$38.2M 1.15%
519,722
-1,330,649
-72% -$94M
REGN icon
40
PUT
Regeneron Pharmaceuticals
REGN
$68.8B
$34.4M 1.04%
+98,400
New +$37.9M
UHS icon
41
Universal Health Services
UHS
$9.43B
$33.5M 1.01%
249,510
-291,946
-54% -$38.5M
BPMC
42
DELISTED
Blueprint Medicines
BPMC
$33.3M 1.01%
1,646,516
+226,005
+16% +$4.11M
ARAY icon
43
Accuray
ARAY
$28.4M
$30M 0.91%
5,780,693
-103,525
-2% -$566K
JAZZ icon
44
CALL
Jazz Pharmaceuticals
JAZZ
$15.9B
$28.9M 0.87%
204,700
-7,300
-3% -$1.08M
OEF icon
45
PUT
iShares S&P 100 ETF
OEF
$19.8B
$28.2M 0.85%
+109,400
New +$10.1M
DVN icon
46
Devon Energy
DVN
$51.9B
$27.3M 0.82%
+754,242
New +$25.6M
CLVS
47
DELISTED
Clovis Oncology, Inc.
CLVS
$27.3M 0.82%
1,986,582
+112,198
+6% +$1.64M
BABA icon
48
Alibaba
BABA
$269B
$26.3M 0.79%
330,735
+170,639
+107% +$13.4M
VMC icon
49
Vulcan Materials
VMC
$36.3B
$20.8M 0.63%
173,008
-320,063
-65% -$36.2M
ELGX
50
DELISTED
Endologix Inc
ELGX
$19.4M 0.59%
+155,894
New +$17.9M
1
2
3 4 5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return

PFM Health Sciences's Q2 2016 Portfolio in Review

As of Q2 2016, PFM Health Sciences held 111 positions worth $3.31B, up 2.2% from $3.24B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

PFM Health Sciences withdrew a net $212M in Q2 2016, closing 33 positions and reducing 21 holdings. Its most notable exit was Lam Research, an estimated $90.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 45% a quarter earlier, followed by Technology and Communication Services.

Against the trend, PFM Health Sciences opened a new position in Biogen worth $81.1M.

  • PFM Health Sciences's largest Q2 2016 buy was Biogen: 335,290 shares worth $81.1M.
  • PFM Health Sciences added most to Aetna Inc in Q2 2016, an estimated $92.4M increase.
  • PFM Health Sciences's biggest Q2 2016 reduction was HCA Healthcare, cutting an estimated $110M.
  • PFM Health Sciences fully exited Lam Research in Q2 2016, selling an estimated $90.7M.
  • PFM Health Sciences's ten largest holdings make up 31% of its $3.31B portfolio in Q2 2016.
  • PFM Health Sciences opened 31 new positions and closed 33 in Q2 2016.
  • PFM Health Sciences's portfolio value rose 2.2% quarter-over-quarter to $3.31B.

Based on PFM Health Sciences's 13F filing for Q2 2016, filed 15 Aug 2016.